The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2

Journal of Clinical Investigation

Volumn 97, Issue 1, 1996, Pages 250-257

  Weinrauch, Yvette ^a   Elsbach, Peter ^a   Madsen, Lisa M ^a   Foreman, Amy ^a   Weiss, Jerrold ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ascitic fluid; bacteria; inflammation; phospholipid degradation

Indexed keywords

PHOSPHOLIPASE A2;

ANTIBACTERIAL ACTIVITY; ARTICLE; ASCITES FLUID; CATALYSIS; GRAM POSITIVE BACTERIUM; LIPOLYSIS; NONHUMAN; PERITONEUM EXUDATE; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS AUREUS;

EID: 0030070567     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118399     Document Type: Article

References (53)

1. Elsbach, P., and J. Weiss. 1992. Oxygen-independent antimicrobial systems of phagocytes, in Inflammation: Basic Principles and Clinical Correlates. J I. Gallin, I. M. Goldstein, and R. Snyderman, editors. Raven Press, New York. 603-636.
2. Klebanoff, S. J. 1992. Oxygen metabolites from phagocytes. In Inflammation: Basic Principles and Clinical Correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman, editors. Raven Press, New York. 541-588.
3. Gabay, J. E. 1994. Ubiquitous natural antibiotics. Science (Wash. DC) 264 373-374.
4. Jensen, R. S. J. G. Tew, and D. M. Donaldson 1967. Extracellular β-lysin and muramidase in body fluids and inflammatory exudates. Proc, Soc. Exp. Biol. Med. 124:545-549.
5. Donaldson D. M., and J G. Tew. 1977. Beta-lysin of platelet origin. Bacteriol Rev. 41:501-513.
6. Weinrauch, Y., A. Foreman, C. Shu, K. Zarember, O. Levy, P. Elsbach, and J. Weiss. 1995. Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate. J. Clin Invest. 95:1916-1924.
7. Hirsch, J G. 1956. Phagocytin: a bactericidal substance from polymorphonuclear leukocytes. J. Exp. Med. 103:589-621.
8. Myrvik, Q. N. 1956. Serum bactericidins active against gram positive bacteria. Ann. NY Acad. Sci 66:391-400.
9. Skarnes, R. C., and D. W. Watson. 1957. Antimicrobial factors of normal tissues and fluids. Bacteriol Rev 21:273-294.
10. Carroll, S F., and R. J. Martinez. 1981. Antibacterial peptide from normal rabbit serum. I. Isolation from whole serum, activity, and microbicidal spectrum. Biochemistry 20:5973-5981
11. Higashi, Y., H. Saito, Y. Yanagase, K. Yonemasu, and T. Amano. 1966. Studies on the role of plakin. XI Demonstration of phospholipase A in plakin Biken J. 9.249-262.
12. Kini, R. M., and H. J. Evans. 1987. Structure-function relationships of phospholipases. The anticoagulant region of phospholipases A2. J. Biol Chem 262:14402-14407.
13. Inada, M., R. M. Crowl, A. C. Bekkers, H, Verheij, and J. Weiss. 1994. Determinants of the inhibitory action of purified 14-kDa phospholipases A2 on cell-free prothrombinase complex. J Biol. Chem 269:26338-26343.
14. Weiss, J., G. Wright, A. C. A. P. A. Bekkers, C. J. van den Bergh, and H. M. Verheij. 1991. Conversion of pig pancreas phospholipase A2 by protein engineering into enzyme active against Escherichia coli treated with the bactericidal/permeability-increasing protein. J. Biol Chem. 266:4162-4167.
15. Weiss, J., M. Inada, P. Elsbach, and R. M. Crowl. 1994. Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytes. J. Biol. Chem 269.26331-26337.
16. Forst, S., J. Weiss, P. Elsbach, J. M. Maraganore, I Reardon, and R. L Heinrikson. 1986. Structural and functional properties of a phospholipase A2 purified from an inflammatory exudate. Biochemistry. 25:8381-8385
17. Wright, G. W., C. E. Ooi, J. Weiss, and P. Elsbach. 1990. Purification of a cellular (granulocyte) and an extracellular (serum) phospholipase A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate. J Biol. Chem 265:6675-6681.
18. Fischer, W 1994. Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus. Med. Microbiol. Immunol. 183:61-76.
19. Bligh, E. S , and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
20. Elsbach, P , and J. Weiss. 1991 Utilization of labeled Escherichia coli as phospholipase substrate. Methods Enzymol. 197:24-31.
21. White, D. C., and A. N. Tucker. 1969. Phospholipid metabolism during bacterial growth. J. Lipid. Res. 10:220-233.
22. Kates, M., and A. J. Hancock. 1976 Synthesis of monophytanyl ether analogues of lysophosphatidic and lysophosphatidyl glycerol. Chem. Phys. Lipids. 17:155-168.
23. Wright, G. C., J. Weiss, K. S Kim, H Verheij, and P. Elsbach. 1990 Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils Role of cellular and extracellular phospholipases. J Clin. Invest 85:1925-1935.
24. Johnson, F. B , and D. M Donaldson. 1968. Purification of staphylocidal β-lysin from rabbit serum. J Bacteriol. 96.589-595.
25. Dennis, E. A. 1994. Diversity of group types, regulation, and function of phospholipase A2. J. Biol Chem 269:13057-13060.
26. Lambeau, G., A Schmid-Alliana, M. Lazdunski, and J Barhanin. 1990 Identification and purification of a very high affinity binding protein for toxic phospholipases A2 in skeletal muscle. J. Biol. Chem 265:9526-9532.
27. Lambeau, G., J. Barhanin, and M. Lazdunski. 1991. Identification of different receptor types for toxic phospholipases A2 in rabbit skeletal muscle. FEBS Lett 293:29-33.
28. Hanasaki, K., and H. Arita 1992. Characterization of a high affinity binding site for pancreatic-type phospholipase A2 in the rat. Its cellular and tissue distribution. J Biol Chem. 267:6414-6420.
29. Pruzanski, W , P. Vadas, and J Browning. 1993. Secretory non-pancreatic group II phospholipase A2. role in physiologic and inflammatory processes J. Lipid Mediators. 8:161-167.
30. Stoner, C. R., L. M. Reik, M. Donohue, W. Levin, and R. M. Crowl. 1991 Human group II phospholipase A2. Characterization of monoclonal antibodies and immunochemical quantitation of the protein in synovial fluid. J. Immunol Methods 145:127-136
31. Kramer, R M., and R. B. Pepinsky 1991. Assay and purification of phospholipase A2 from human synovial fluid in rheumatoid arthritis. Methods Enzymol. 197:373-381.
32. Marsh, J., and J. A. Goode. 1994. Antimicrobial Peptides John Wiley & Sons, Inc , London.
33. Taylor, P. W 1983. Bactericidal and bacteriolytic activity of serum against Gram-negative bacteria. Microbiol. Rev. 47:46-83
34. Elbach, P., J Weiss, and O. Levy. 1994. Integration of antimicrobial host defenses: role of the bactericidal/permeability-increasing protein. Trends Microbiol. 2 324-328.
35. Weiss, J., S. Beckerdite-Quagliata, and P. Elsbach. 1979. Determinants of the action of phospholipases A on the envelope phospholipids of Escherichia coll. J Biol. Chem 254:11010-11014
36. 2. Rev. Physiol. Biochem Pharmacol 91:91-203.
37. 2-terminal lysines in action on phospholipids of Escherichia coli. Biochemistry, 25:4309-4314.
38. Forst, S., J. Weiss, J. M. Maraganore, R. L Heinrikson, and P. Elsbach. 1987. Relation between binding and the action of phospholipases A2 on Escherichia coli exposed to the bactericidal/permeability-h«#2%!sing protein of neutrophils. Biochim. Biophys Acta 920:221-225.
39. Holtje, J.-V., and A. Tomasz. 1975. Lipoteichoic acid: a specific inhibitor of autolysin activity in pneumococcus. Proc. Natl Acad. Sci. USA 72:1690-1694.
40. 2--dependent phospholipases. J Biol Chem. 260:1618-1622.
41. 2. Biochim. Biophys. Acta. 1171:217-231.
42. Vadas, P., J Browning, J. Edelson, and W. Pruzanski. 1993. Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease states J. Lipid Mediators. 8:1-30.
43. Harwig, S. S., L Tan, X D. Ou, Y. Cho, P. B. Eisenhauer, and R. I. Lehrer. 1995. Bactericidal properties of murine intestinal phospholipase A2. J. Clin Invest 95:603-610.
44. Crowl, R. M , T. J Stoller, R R Conroy, and C. R Stoner. 1991. Induction of phosopholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J. Biol Chem. 266:2647-2651.
45. Nevalainen, T. J., H. J. Aho, and H. Peuravuori. 1994. Secretion of group 2 phospholipase A2 by lacrimal glands, Invest Ophthalmol. & Visual Sci. 35:417-421.
46. Murakami, M., I. Kudo, and K. Inoue. 1989. In vivo release and clearance of rat platelet phospholipase A2. Biochim. Biophys. Acta. 1005:270-276.
47. Santos, A. A., J. L. Browning, M. R. Scheltinga, E A. Lynch, E. F. Brown, P. Lawton, E. Chambers, I. Douglas, C. D. Benjamin, C. A. Dinarello, et al 1994. Are events after endotoxemia related to circulating phospholipase A2? Ann. Surg. 219:183-192
48. Horigome, K., M. Hayakawa, K. Inoue, and S. Nojima. 1987. Selective release of phospholipase A2 and lysophosphatidylserine-specific lysophospholipase from rat platelets. J. Biochem. 101.53-61.
49. Mizushima, H , I. Kudo, K. Horigome, M Murakami, M. Hayakawa, D. K. Kim, E. Kondo, M Tomita, and K. Inoue. 1989. Purification of rabbit platelet secretory phospholipase A2 and its characteristics. J. Biochem. 105: 520-525.
50. Cohen, M. L. 1992. Epidemiology of drug resistance: implications for a post-antibiotic era Science (Wash DC). 257:1050-1055.
51. Archer, G. L., and D. M. Niemeyer. 1994. Origin and evolution of DNA associated with resistance to methicillin in staphylococci. Trends Microbiol. 2:343-347.
52. Waldvogel, F A 1995. Staphylococcus aureus (including toxic shock syndrome). In Principles and Practice of Infectious Diseases. G. L. Mandell, R. G. Douglas, Jr., and J. E. Bennett, editors. John Wiley & Sons, New York. 1754-1775.
53. Elsbach, P., and J. Weiss 1988. Phagocytosis of bacteria and phospholipid degradation. Biochim. Biophys Acta. 947:29-52.